INTERIM REPORT JANUARY-SEPTEMBER 2015

THE JANUARY-SEPTEMBER PERIOD 2015 IN BRIEF · Net sales amounted to MSEK 11.7 (22.0), whereof the third quarter MSEK 9.4 (8.8) · Net loss was MSEK 53.5 (37.5), whereof the third quarter MSEK 16.6 (9.9) · Loss per share was SEK 1.14 (1.01), whereof the third quarter SEK 0.35 (0.27) · Cash flow from operating activities was MSEK -46.7 (-35.7), whereof the third quarter MSEK -14.3 (-9.4) · Cash and cash equivalents and other short-term investments at the end of the period totaled MSEK 132.1 (62.3) · Acquisition of the companies Apropharm AS and DNE Sverige AB SIGNIFICANT